{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:14:27Z","timestamp":1791202467714,"version":"4.2.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.amjmed.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T07:11:14Z","timestamp":1360739474000},"page":"S12-S18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"S1","title":["The Effect of Opioid Therapy on Endocrine Function"],"prefix":"10.1016","volume":"126","author":[{"given":"Michael J.","family":"Brennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 10","key":"10.1016\/j.amjmed.2012.12.001_bib1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/AJP.0b013e31816b58eb","article-title":"Management of expected and unexpected opioid-related side effects","volume":"24","author":"Harris","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","article-title":"The impact of opioids on the endocrine system","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0885-3924(02)00404-9","article-title":"Opioids causing peripheral edema","volume":"23","author":"Gardner-Nix","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.amjmed.2012.12.001_bib4","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function","author":"Ninkovi\u0107","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.amjmed.2012.12.001_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1001\/jama.294.14.1810","article-title":"Palliative sedation in dying patients: \u201cwe turn to it when everything else hasn't worked.\u201d","volume":"294","author":"Lo","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2012.12.001_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","article-title":"Hyperalgesia: an emerging iatrogenic syndrome","volume":"26","author":"Mercadante","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.amjmed.2012.12.001_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00408-010-9254-3","article-title":"Obstructive sleep apnea and chronic opioid use","volume":"188","author":"Guilleminault","year":"2010","journal-title":"Lung"},{"key":"10.1016\/j.amjmed.2012.12.001_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/jpai.2002.126790","article-title":"Hypogonadism in men consuming sustained-action oral opioids","volume":"3","author":"Daniell","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","volume":"25","author":"Saunders","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1743-6109.2007.00702.x","article-title":"Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment","volume":"5","author":"Hallinan","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of hypogonadism in males aged at least 45 years: the HIM study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"3 pt 2","key":"10.1016\/j.amjmed.2012.12.001_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9343(88)90144-1","article-title":"Endocrine disorders in men infected with human immunodeficiency virus","volume":"84","author":"Dobs","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0950-351X(98)80096-7","article-title":"Androgen therapy in AIDS wasting","volume":"12","author":"Dobs","year":"1998","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ijir.2009.46","article-title":"Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses","volume":"22","author":"Guay","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.amjmed.2012.12.001_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1378\/chest.123.2.632","article-title":"Sleep-disordered breathing associated with long-term opioid therapy","volume":"123","author":"Farney","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2012.12.001_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4637.2007.00343.x","article-title":"Sleep-disordered breathing and chronic opioid therapy","volume":"9","author":"Webster","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib18","first-page":"20","article-title":"Opioid-induced endocrinopathy","volume":"109","author":"Colameco","year":"2009","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.amjmed.2012.12.001_bib19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2605.1988.tb00984.x","article-title":"Gonadal function in male heroin and methadone addicts","volume":"11","author":"Ragni","year":"1988","journal-title":"Int J Androl"},{"key":"10.1016\/j.amjmed.2012.12.001_bib22","first-page":"441","article-title":"Effects of heroin on thyroid function, cortisol and testosterone level in addicts","volume":"47","author":"Rasheed","year":"1995","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib23","first-page":"210","article-title":"Heroin addiction and sex hormones in males","volume":"42","author":"Malik","year":"1992","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.amjmed.2012.12.001_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cpt1975175529","article-title":"Plasma testosterone levels during chronic heroin use and protracted abstinence: a study of Hong Kong addicts","volume":"17","author":"Mendelson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2012.12.001_bib25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1056\/NEJM197504242921703","article-title":"Function of the male sex organs in heroin and methadone users","volume":"292","author":"Cicero","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(25)30047-9","article-title":"Plasma testosterone levels in heroin addiction and during methadone maintenance","volume":"192","author":"Mendelson","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjmed.2012.12.001_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002508-200009000-00011","article-title":"Hypogonadism in patients treated with intrathecal morphine","volume":"16","author":"Finch","year":"2000","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib28","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00002508-200205000-00002","article-title":"Sex hormone suppression by intrathecal opioids: a prospective study","volume":"18","author":"Roberts","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2008-1076715","article-title":"Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women","volume":"117","author":"Fraser","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.amjmed.2012.12.001_bib32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0885-3924(03)00331-2","article-title":"Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy","volume":"26","author":"Rajagopal","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.amjmed.2012.12.001_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cncr.20028","article-title":"Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids","volume":"100","author":"Rajagopal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.amjmed.2012.12.001_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archinte.164.3.338-a","article-title":"Opioid osteoporosis [letter]","volume":"164","author":"Daniell","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib35","first-page":"539","article-title":"Does opioid use for pain management warrant routine bone mass density screening in men?","volume":"11","author":"Fortin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.amjmed.2012.12.001_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amjmed.2012.12.001_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00198-008-0711-2","article-title":"Mapping the prescriptiome to fractures in men\u2014a national analysis of prescription history and fracture risk","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.amjmed.2012.12.001_bib38","doi-asserted-by":"crossref","first-page":"1414.e7","DOI":"10.1016\/j.amjmed.2005.07.033","article-title":"Bone mineral density in subjects using central nervous system-active medications","volume":"118","author":"Kinjo","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archinte.163.8.949","article-title":"Central nervous system active medications and risk for fractures in older women","volume":"163","author":"Ensrud","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib40","first-page":"1775","article-title":"Clinical review 106: amenorrheic bone loss","volume":"84","author":"Miller","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000054586","article-title":"Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells","volume":"72","author":"P\u00e9rez-Castrill\u00f3n","year":"2000","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.amjmed.2012.12.001_bib42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1359\/jbmr.1998.13.10.1515","article-title":"The enkephalinergic osteoblast","volume":"13","author":"Rosen","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.amjmed.2012.12.001_bib43","first-page":"998","article-title":"Lower serum osteocalcin levels in pregnant drug users and their newborns at the time of delivery","volume":"75","author":"Rico","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0024-3205(89)90631-0","article-title":"The response to analgesia testing is affected by gonadal steroids in the rat","volume":"45","author":"Forman","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.amjmed.2012.12.001_bib45","first-page":"423","article-title":"Role of testosterone on pain threshold in rats","volume":"39","author":"Pednekar","year":"1995","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/s0304-3959(02)00457-8","article-title":"Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats","volume":"103","author":"Stoffel","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00213-002-1143-x","article-title":"Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats","volume":"163","author":"Terner","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.amjmed.2012.12.001_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpain.2005.10.009","article-title":"Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency","volume":"7","author":"Daniell","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib49","first-page":"2717","article-title":"Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib50","first-page":"269","article-title":"Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis","volume":"19","author":"Palm","year":"1997","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib51","first-page":"509","article-title":"Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone","volume":"114","author":"Allolio","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.amjmed.2012.12.001_bib52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jpain.2006.04.011","article-title":"DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production","volume":"7","author":"Daniell","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.amjmed.2012.12.001_bib53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.maturitas.2005.07.004","article-title":"Comparison of screening questionnaires for the diagnosis of hypogonadism","volume":"53","author":"Morley","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.amjmed.2012.12.001_bib54","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib55","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib56","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2164\/jandrol.108.006486","article-title":"Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations","volume":"30","author":"Wang","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.amjmed.2012.12.001_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2164\/jandrol.109.009597","article-title":"Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial","volume":"31","author":"Wang","year":"2010","journal-title":"J Androl"},{"key":"10.1016\/j.amjmed.2012.12.001_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib60","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.ju.0000136269.10161.32","article-title":"Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men","volume":"172","author":"Kaufman","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.ju.0000143942.55896.64","article-title":"Testosterone replacement therapy after primary treatment for prostate cancer","volume":"173","author":"Agarwal","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1743-6109.2009.01161.x","article-title":"Testosterone replacement therapy following radical prostatectomy","volume":"6","author":"Khera","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cncr.22438","article-title":"Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy","volume":"109","author":"Sarosdy","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.amjmed.2012.12.001_bib64","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.juro.2010.11.084","article-title":"Testosterone therapy in men with untreated prostate cancer","volume":"185","author":"Morgentaler","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.amjmed.2012.12.001_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2012.12.001_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2605.2007.00824.x","article-title":"Hypogonadism in men receiving methadone and buprenorphine maintenance treatment","volume":"32","author":"Hallinan","year":"2009","journal-title":"Int J Androl"},{"key":"10.1016\/j.amjmed.2012.12.001_bib67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2012.12.001_bib68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jpainsymman.2009.06.002","article-title":"Establishing \u201cbest practices\u201d for opioid rotation: conclusions of an expert panel","volume":"38","author":"Fine","year":"2009","journal-title":"J Pain Symptom Manage"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431200959X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431200959X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:00:54Z","timestamp":1757581254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431200959X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S000293431200959X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.12.001","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Opioid Therapy on Endocrine Function","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}